Earlier and more aggressive treatment with biologics may prevent relapses and further new organ involvement in Behçet's disease

Immunosuppressives (IS) are the choice of treatment for major organ involvement in Behçet's disease (BD). In this study, we aimed to investigate the relapse rate and new major organ development in BD under ISs during long-term follow-up. The files of 1114 BD patients followed in Marmara Univers...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical immunology (Orlando, Fla.) Fla.), 2023-03, Vol.248, p.109263-109263, Article 109263
Hauptverfasser:	Bozkurt, Tugce, Karabacak, Murat, Karatas, Hakan, Kutluğ Ağaçkıran, Seda, Ergun, Tulin, Direskeneli, Haner, Alibaz-Oner, Fatma
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Behcet Syndrome Behçet's disease Biological Products Humans Immunosuppressive Agents Immunosuppressives Major organ involvement Male Recurrence Relapse Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!